Skip to content

Optimer for robust affinity chromatography ligands

Watch as CTO, Dr David Bunka, discusses the use of Optimer® binders as tuneable affinity chromatography ligands to support the development of novel drugs, during the 2021 Biologics Europe Digital Conference.

Find out the use of specific conditions in the discovery process can support optimised binding parameters, including, rapid ‘on-rate’, slow ‘off-rates’, and induced release under mild buffer conditions, for improved yield of functional product.


#bioprocessing #optimer #affinitypurification

Start your next project with Aptamer Group

Contact one of our experts today